Atorvastatin cuts anthracycline heart failure

Published Date: 08 Mar 2023

Atorvastatin 40 mg daily for 12 months reduces cardiovascular events in lymphoma patients treated with anthracyclines.

Read Full News

Latest News

ApoB May Be Better Treatment Target Than LDL-C

A new study suggests apolipoprotein B may be a more targeted and cost-effective way to guide lipid-lowering therapy in primary prevention.

Pioneers Who Changed Clinical Practice

A soldier’s wound, a makeshift apartment lab and a risky self experiment: how curiosity, chance, and persistence led to discoveries that underpin today’s diagnostics and treatments.

Yoga Can Reduce Blood Pressure in Adults With High BMI

Yoga practice is associated with substantial reductions in systolic and diastolic blood pressure among adults with overweight or obesity, according to a meta-analysis of 30 studies.

Poststroke Epilepsy Carries Higher Risk for Dementia

Poststroke epilepsy is linked to a significantly higher risk for dementia, suggesting a need for increased surveillance and interventions to prevent epilepsy in patients with stroke.

SSRI Added to Antipsychotics May Raise Cardiac Risk

Concurrent use of SSRI and antipsychotics is associated with a significantly increased risk for ventricular arrhythmia or sudden death, new research shows.

Carotid Revascularization May Lower Seizure Risk in Stenosis

Carotid revascularization is linked to a reduced risk for both short- and long-term seizures or epilepsy in patients with carotid stenosis, new research shows.

Todays Updates

Which Risk Model Better Identifies High-Risk Smoldering MM?

A cohort study compares the distribution and progression risk among individuals classified as having high-risk smoldering multiple myeloma by the AQUILA trial inclusion criteria vs 2/20/20 risk model.

Todays Updates

Which Risk Model Better Identifies High-Risk Smoldering MM?

A cohort study compares the distribution and progression risk among individuals classified as having high-risk smoldering multiple myeloma by the AQUILA trial inclusion criteria vs 2/20/20 risk model.

Latest News

A new study suggests apolipoprotein B may be a more targeted and cost-effective way to guide lipid-lowering therapy in primary prevention.

A soldier’s wound, a makeshift apartment lab and a risky self experiment: how curiosity, chance, and persistence led to discoveries that underpin today’s diagnostics and treatments.

Yoga practice is associated with substantial reductions in systolic and diastolic blood pressure among adults with overweight or obesity, according to a meta-analysis of 30 studies.

Poststroke epilepsy is linked to a significantly higher risk for dementia, suggesting a need for increased surveillance and interventions to prevent epilepsy in patients with stroke.

Concurrent use of SSRI and antipsychotics is associated with a significantly increased risk for ventricular arrhythmia or sudden death, new research shows.

Carotid revascularization is linked to a reduced risk for both short- and long-term seizures or epilepsy in patients with carotid stenosis, new research shows.

News All Time

Trial Data May Shift Coronary Artery Disease Treatment

Emerging evidence may help reshape antiplatelet and lipid strategies for the management of coronary artery disease.

Refined Grains May Not Be Good for People With Heart Failure

Eating more than three servings of refined grains per day was associated with a greater risk for adverse clinical outcomes in people with heart failure vs diets focusing on vegetables and legumes.

Competing Stroke Causes Common in AF Despite Anticoagulation

Nearly 1 in 4 patients with atrial fibrillation who experience an ischaemic stroke despite oral anticoagulation have additional competing stroke aetiologies.

Loneliness Tied to Degenerative Valvular Heart Disease Risk

Loneliness is linked to an increased risk for degenerative valvular heart disease and could be a modifiable risk factor for at-risk patients.

One Pill, Three Meds, Fewer Strokes After ICH

Final results of the TRIDENT trial show that a single pill containing low doses of three different antihypertensives dramatically reduces recurrent stroke in patients with ICH.

Poor Muscle Composition Tied to Mortality in Kidney Disease

Adverse muscle composition is independently associated with an increased risk for all-cause mortality in patients with chronic kidney disease, a UK-based study finds.

Waist Size Can Signal Risk for Heart Disease in T1D

A higher waist-to-height ratio is independently linked to an increased risk for coronary artery disease in patients with type 1 diabetes, according to a 19-year cohort study.

FXIa Inhibitor Hits Mark in Recurrent Stroke Prevention

Full results from the OCEANIC-STROKE trial show a 26% reduction in recurrent stroke with the factor XIa inhibitor asundexian, with no increased bleeding risk.

His Cancer Diagnosis in Medical School Changed Everything

A childhood diagnosis inspired Hunter Bohon to go into medicine. A cancer diagnosis at 26 changed what kind of doctor he wants to be.

Challenges of Placebo Arms in Weight-Loss Drug Trials

Drugmakers continue to test weight-loss medicines against dummy pills and shots, even with a growing number of effective approved obesity drugs. This practice raises practical questions.

One-Month Limit Imposed on Ramipril 1.25-mg Supplies

New shortage protocol allows UK pharmacists to restrict dispensing as supply pressures hit a drug used by millions.

Sleep, Diet, Exercise Linked to Lower Cardiovascular Risk

Mobile health devices offer potential for cardiac monitoring, but false positives and integration challenges limit their current clinical use.

Early Childhood Movement Tied to Active Lifestyle Later

Three movement habits in toddlerhood — active play with parents, limited screen time, and sufficient sleep — predict a more physically active lifestyle a decade later.

Real-World Data Back TTVR for Older Adults With Severe TR

Transcatheter tricuspid valve replacement safely improved outcomes outside a clinical trial setting.

Cardiac Rehab Remains Underutilized Despite Benefits

Cardiac rehabilitation after transcatheter aortic valve implantation is associated with reduced risk for unplanned rehospitalization, yet it remains underutilized.

Interval Training Boosts Fitness in Patients With ICD

Supervised high-intensity interval training significantly improves exercise capacity and quality of life in patients with an implantable cardioverter defibrillator.

Recommended News For You

Detecting pancreatic cancer through changes in body composition and metabolism

Formaldehyde releasers found in common personal care products used especially by Black and Latina women

FDA OKs Upfront Nivolumab+Chemo for Classic Hodgkin Lymphoma

The FDA approves Enhertu for HER2-positive cancers, regardless of tumor type.

A three-quarters reduction in the risk of prostate cancer is associated with an annual increase in cardiorespiratory fitness of more than three percent.

Treating advanced prostate cancer

Metastatic breast cancer can be effectively treated with cyclical estrogen and anti-estrogen therapy.

Recommended Articles For You

Unlocking the Potential of CPK Levels: How to Maximize Your Health Benefits 

New Research Advances in the Treatment of Multiple Myeloma and Plasmacytoma  

Potential of Device-Assisted Therapy in Non-Muscle-Invasive Bladder Cancer 

Unlocking the Power of Hematocrit: Exploring the Benefits of Blood Cell Counts 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Single-dose radiation before surgery can eradicate breast cancer

2.

Never in a million years did I think I'd have to limit my chemotherapy.

3.

Novel topical fluorescent imaging technique rapidly and safely detects basal cell carcinoma

4.

Virtual Reality Travel Reduces Cancer Pain.

5.

The Truth About Apple AirPods

1.

All You Need To Know About Cancer Antigen 27-29: Causes, Symptoms & Treatment

2.

A Comprehensive Guide To Understanding Plasma Osmolality

3.

The Rise of Immunotherapy: New Advances in Cancer Treatment

4.

Unlocking the Potential of Bicalutamide 50 mg: A Revolutionary New Treatment for Prostate Cancer

5.

Unveiling the Secrets of Early Cancer: Emerging Strategies to Decipher Its Biology

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII

2.

Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion

3.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part IV

4.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part II

5.

Managing ALK+ NSCLC while Ensuring Long-Term Safety of the Patients

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot